Company / Interest Expense
Elicio Therapeutics, Inc. Interest Expense History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
-$1.8M
FY2022
5-year range
-$8.8M / -$1.8M
FY2021-FY2022
Trend
+79.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$2M in FY2022.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, interest expense increased 79.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.36 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$1.8M | +79.1% |
| FY2021 | -$8.8M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026